Phio Pharmaceuticals Corp. (PHIO) Misses Q2 EPS by 45c
Tweet
Share
E-mailGet Alerts PHIO Hot Sheet
Join SI Premium – FREE
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q2 EPS of ($0.45).
For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
- Raymond James Downgrades Accelerant Holdings (ARX) to Underperform
- Compass Therapeutics (CMPX) PT Lowered to $4 at Citizens After FDA Dialogue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
